Total Payments
$369.42
2024 Payments
$99.62
Companies
10
Transactions
12
Medicare Patients
1,135
Medicare Billing
$130,689
Payment Breakdown by Category
Food & Beverage$257.43 (69.7%)
Education$111.99 (30.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $257.43 | 10 | 69.7% |
| Education | $111.99 | 2 | 30.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $105.55 | 2 | $0 (2018) |
| Tempus AI, Inc | $42.38 | 2 | $0 (2024) |
| Exelixis Inc. | $41.28 | 1 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $37.70 | 1 | $0 (2018) |
| ABBVIE INC. | $32.51 | 1 | $0 (2024) |
| Daiichi Sankyo Inc. | $26.21 | 1 | $0 (2023) |
| Celgene Corporation | $24.73 | 1 | $0 (2024) |
| Lilly USA, LLC | $24.30 | 1 | $0 (2018) |
| Coherus Biosciences Inc. | $22.76 | 1 | $0 (2020) |
| Alexion Pharmaceuticals, Inc. | $12.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $99.62 | 4 | Tempus AI, Inc ($42.38) |
| 2023 | $26.21 | 1 | Daiichi Sankyo Inc. ($26.21) |
| 2022 | $12.00 | 1 | Alexion Pharmaceuticals, Inc. ($12.00) |
| 2020 | $22.76 | 1 | Coherus Biosciences Inc. ($22.76) |
| 2019 | $41.28 | 1 | Exelixis Inc. ($41.28) |
| 2018 | $167.55 | 4 | Janssen Biotech, Inc. ($105.55) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $32.51 | General |
| Category: ONCOLOGY | ||||||
| 07/22/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.73 | General |
| Category: Hematology | ||||||
| 04/24/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $21.74 | General |
| 02/14/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $20.64 | General |
| 10/16/2023 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Iron Deficiency Anemia | ||||||
| 01/27/2022 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological) | Education | In-kind items and services | $12.00 | General |
| Category: Rare Disease | ||||||
| 12/22/2020 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 04/17/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $41.28 | General |
| Category: Oncology | ||||||
| 07/18/2018 | Bayer HealthCare Pharmaceuticals Inc. | Aliqopa (Drug) | Food and Beverage | In-kind items and services | $37.70 | General |
| Category: Oncology | ||||||
| 07/16/2018 | Janssen Biotech, Inc. | IMBRUVICA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Oncology | ||||||
| 05/11/2018 | Janssen Biotech, Inc. | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Immunology | ||||||
| 04/18/2018 | Lilly USA, LLC | VERZENIO (Drug) | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 262 | 457 | $124,220 | $28,082 |
| 2022 | 6 | 273 | 500 | $139,899 | $32,007 |
| 2021 | 8 | 305 | 540 | $151,565 | $36,716 |
| 2020 | 6 | 295 | 560 | $167,354 | $33,886 |
Total Patients
1,135
Total Services
2,057
Medicare Billing
$130,689
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 141 | 260 | $55,380 | $12,199 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 136 | $42,704 | $9,881 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 26 | 35 | $14,770 | $3,667 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $6,611 | $1,452 | 22.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,755 | $883.94 | 18.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 79 | 175 | $54,950 | $12,558 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 135 | 259 | $55,167 | $12,310 | 22.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 26 | $10,972 | $2,915 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $8,712 | $1,950 | 22.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 11 | 11 | $6,611 | $1,617 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $3,487 | $656.94 | 18.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 80 | 181 | $56,834 | $13,835 | 24.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 125 | 231 | $49,203 | $11,270 | 22.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 38 | $16,036 | $4,242 | 26.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 23 | 23 | $11,132 | $2,522 | 22.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $7,212 | $1,798 | 24.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 26 | $5,460 | $1,501 | 27.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 13 | $3,848 | $1,055 | 27.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 14 | 16 | $1,840 | $493.28 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 89 | 195 | $61,230 | $11,686 | 19.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 38 | 93 | $39,246 | $8,207 | 20.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 110 | 175 | $37,275 | $6,663 | 17.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 29 | 68 | $14,280 | $4,030 | 28.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $8,712 | $1,912 | 21.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 11 | 11 | $6,611 | $1,389 | 21.0% |
About Dr. Simbo Aduloju, M.D
Dr. Simbo Aduloju, M.D is a Hematology & Oncology healthcare provider based in Decatur, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1770769234.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Simbo Aduloju, M.D has received a total of $369.42 in payments from pharmaceutical and medical device companies, with $99.62 received in 2024. These payments were reported across 12 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($257.43).
As a Medicare-enrolled provider, Aduloju has provided services to 1,135 Medicare beneficiaries, totaling 2,057 services with total Medicare billing of $130,689. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Decatur, GA
- Active Since 01/15/2008
- Last Updated 08/25/2020
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1770769234
Products in Payments
- IMBRUVICA (Drug) $99.99
- Cabometyx (Drug) $41.28
- Aliqopa (Drug) $37.70
- EPKINLY (Drug) $32.51
- INJECTAFER (Drug) $26.21
- REBLOZYL (Biological) $24.73
- VERZENIO (Drug) $24.30
- Udenyca (Biological) $22.76
- SOLIRIS (Biological) $12.00
- STELARA (Biological) $5.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Decatur
Sebastien Kairouz, M.d, M.D
Hematology & Oncology — Payments: $41,840
Hematology & Oncology $41,840
Dr. Bruce Feinberg, Do, DO
Hematology & Oncology — Payments: $30,799
Hematology & Oncology $30,799
Mr. Perry Guaglianone, M.d, M.D
Hematology & Oncology — Payments: $19,173
Hematology & Oncology $19,173
Ana Antun, M.d, M.D
Hematology & Oncology — Payments: $17,709
Hematology & Oncology $17,709
Dr. Benjamin Esparaz, M.d, M.D
Hematology & Oncology — Payments: $14,881
Hematology & Oncology $14,881
Dr. Sammy Becdach, M.d, M.D
Hematology & Oncology — Payments: $8,595
Hematology & Oncology $8,595